Literature DB >> 17852840

Mutations in CARD15 and smoking confer susceptibility to Crohn's disease in the Danish population.

Anja Ernst1, Bent Jacobsen, Mette Østergaard, Henrik Okkels, Vibeke Andersen, Enrika Dagiliene, Inge S Pedersen, Niels Thorsgaard, Asbjørn M Drewes, Henrik B Krarup.   

Abstract

OBJECTIVE: Three CAspase Recruitment Domain (CARD15) mutations have shown to predispose to Crohn's disease in Caucasian populations. The aim of this study was to investigate the mutation frequency in patients with inflammatory bowel disease and in healthy controls in Denmark.
MATERIAL AND METHODS: Genotyping of the three common CARD15 mutations was carried out on 388 patients with Crohn's disease, 565 patients with ulcerative colitis and 796 healthy controls using real-time PCR. Allele and genotype frequencies in the three groups were compared. A possible additive effect of smoking on CARD15 mutations was also examined.
RESULTS: Carrying at least one CARD15 mutation was significantly more common in patients with Crohn's disease compared with healthy controls (21% versus 10%; p <0.001). A gene-dosage effect was observed (ORadj.smoking 22.2; p <0.001 for carrying two CARD15 mutations versus ORadj.smoking 1.8; p=0.01 for carrying one CARD15 mutation). The 1007insC protein truncating mutation was the major contributing mutation. Ileal involvement was more common in Crohn's disease patients with CARD15 mutations as opposed to patients without CARD15 mutations (ORadj.smoking 3.6; p <0.001). Smoking was independently associated with Crohn's disease (OR 1.8; p <0.001), but no multiplicative effect of smoking on CARD15 genotypes was found.
CONCLUSIONS: In the Danish population, CARD15 mutations were found to be associated with Crohn's disease, hence supporting the hypothesis of a genetic component contributing to the disease. Further research for other genes possibly involved in Crohn's disease may result in the use of genetic testing for diagnosis or treatment of Crohn's disease in the future.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17852840     DOI: 10.1080/00365520701427102

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  13 in total

Review 1.  The impact of smoking in Crohn's disease: no smoke without fire.

Authors:  Marian C Aldhous; J Satsangi
Journal:  Frontline Gastroenterol       Date:  2010-09-23

2.  Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease.

Authors:  Vibeke Andersen; Jane Christensen; Anja Ernst; Bent A Jacobsen; Anne Tjønneland; Henrik B Krarup; Ulla Vogel
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

3.  The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study.

Authors:  Vibeke Andersen; Anja Ernst; Jane Christensen; Mette Østergaard; Bent A Jacobsen; Anne Tjønneland; Henrik B Krarup; Ulla Vogel
Journal:  BMC Med Genet       Date:  2010-05-28       Impact factor: 2.103

Review 4.  Differential effects of NOD2 polymorphisms on colorectal cancer risk: a meta-analysis.

Authors:  Yun Tian; Yi Li; Zhenhua Hu; Daqing Wang; Xiyang Sun; Changshan Ren
Journal:  Int J Colorectal Dis       Date:  2009-09-29       Impact factor: 2.571

Review 5.  Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.

Authors:  Tue Bennike; Svend Birkelund; Allan Stensballe; Vibeke Andersen
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

6.  Assessment of heterogeneity between European Populations: a Baltic and Danish replication case-control study of SNPs from a recent European ulcerative colitis genome wide association study.

Authors:  Vibeke Andersen; Anja Ernst; Jurgita Sventoraityte; Limas Kupcinskas; Bent A Jacobsen; Henrik B Krarup; Ulla Vogel; Laimas Jonaitis; Goda Denapiene; Gediminas Kiudelis; Tobias Balschun; Andre Franke
Journal:  BMC Med Genet       Date:  2011-10-13       Impact factor: 2.103

7.  A case-only study of gene-environment interaction between genetic susceptibility variants in NOD2 and cigarette smoking in Crohn's disease aetiology.

Authors:  Katherine L Helbig; Michael Nothnagel; Jochen Hampe; Tobias Balschun; Susanna Nikolaus; Stefan Schreiber; Andre Franke; Ute Nöthlings
Journal:  BMC Med Genet       Date:  2012-03-14       Impact factor: 2.103

8.  Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort.

Authors:  Steffen Bank; Paal Skytt Andersen; Johan Burisch; Natalia Pedersen; Stine Roug; Julied Galsgaard; Stine Ydegaard Turino; Jacob Broder Brodersen; Shaista Rashid; Britt Kaiser Rasmussen; Sara Avlund; Thomas Bastholm Olesen; Hans Jürgen Hoffmann; Bjørn Andersen Nexø; Jacob Sode; Ulla Vogel; Vibeke Andersen
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

9.  The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study.

Authors:  Vibeke Andersen; Lene Agerstjerne; Dorte Jensen; Mette Østergaard; Mona Saebø; Julian Hamfjord; Elin Kure; Ulla Vogel
Journal:  BMC Med Genet       Date:  2009-02-27       Impact factor: 2.103

10.  Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort.

Authors:  Steffen Bank; Paal Skytt Andersen; Johan Burisch; Natalia Pedersen; Stine Roug; Julie Galsgaard; Stine Ydegaard Turino; Jacob Broder Brodersen; Shaista Rashid; Britt Kaiser Rasmussen; Sara Avlund; Thomas Bastholm Olesen; Hans Jürgen Hoffmann; Marianne Kragh Thomsen; Vibeke Ostergaard Thomsen; Morten Frydenberg; Bjørn Andersen Nexø; Jacob Sode; Ulla Vogel; Vibeke Andersen
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.